Heterogeneity of CD4+ and CD8+ T-cell responses to cytomegalovirus in HIV-infected and HIV-uninfected men who have sex with men

Journal of Infectious Diseases

Volumn 210, Issue 3, 2014, Pages 400-404

  Li, Huifen ^a   Margolick, Joseph B ^b   Bream, Jay H ^b   Nilles, Tricia L ^b   Langan, Susan ^b   Bui, Hanhvy T ^b   Sylwester, Andrew W ^c   Picker, Louis J ^c   Leng, Sean X ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

CMV; HIV infection; IE 1; IFN ; IL 2; Intracellular cytokine staining; MACS; Pp65; TNF

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; EARLY ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL HETEROGENEITY; CELL SPECIFICITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; CYTOMEGALOVIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RESPONSE; MALE; MEN WHO HAVE SEX WITH MEN; PRIORITY JOURNAL;

CD4+ AND CD8+ T-CELL RESPONSES; CMV; HIV INFECTION; IE-1; IFN-Γ; IL-2; INTRACELLULAR CYTOKINE STAINING; MACS; PP65; TNF-Α;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS INFECTIONS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE;

EID: 84904298047     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu093     Document Type: Article

References (15)

1. Deeks SG, Verdin E, McCune JM. Immunosenescence and HIV. Curr Opin Immunol 2012; 24:501-6.
2. Vescovini RC, Biasini FF, Fagnoni AR, et al. Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects. J Immunol 2007; 179:4283-91.
3. Koch SA, Larbi D, Ozcelik R, et al. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann N Y Acad Sci 2007; 1114:23-35.
4. Papagno L, Appay V, Sutton J, et al. Comparison between HIV-and CMV-specific T cell responses in long-term HIV infected donors. Clin Exp Immunol 2002; 130:509-17.
5. Stone SF, Price P, Khan N, Moss PA, French MA. HIV patients on antiretroviral therapy have high frequencies of CD8 T cells specific for immediate early protein-1 of cytomegalovirus. AIDS 2005; 19: 555-62.
6. Appay V, Fastenackels S, Katlama C, et al. Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients. AIDS 2011; 25:1813-22.
7. Naeger DM, Martin JN, Sinclair E, et al. Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease. PLoS One 2010; 5:e8886.
8. Leng SX, Qu T, Semba RD, et al. Relationship between cytomegalovirus (CMV) IgG serology, detectable CMV DNA in peripheral monocytes, and CMV pp65(495-503)-specific CD8 (+) T cells in older adults. AGE (Dordr) 2011; 33:607-14.
9. Sylwester AW, Mitchell BL, Edgar JB, et al. Broadly targeted human CMV-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005; 202:673-85.
10. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR Jr. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987; 126:310-8.
11. Desquilbet L, Margolick JB, Fried LP, et al. Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr 2009; 50:299-306.
12. Fried LP, Tangen CM,Walston JD, et al. Frailty in older adults: evidence for a phenotype. J Gerontol 2001; 56A:M146-56.
13. Leng SX, Li HF, Xue QL, et al. Association of detectable cytomegalovirus (CMV) DNA in monocytes rather than positive CMV IgG serology with elevated neopterin levels in community-dwelling older adults. Exp Gerontol 2011; 46:679-84.
14. Maecker HT, Dunn HS, Suni MA, et al. Ues of overlapping peptide mixtures as antigens for cytokine flow cytometry. J Immunol Methods 2001; 255:27-40.
15. Stern-Ginossar N, Weisburd B, Michalski A, et al. Decoding human cytomegalovirus. Science 2012; 338:1088-93.